a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics
Industry Biotechnology
A.I.dvisor indicates that over the last year, AUPH has been loosely correlated with NTLA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if AUPH jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To AUPH | 1D Price Change % | ||
---|---|---|---|---|
AUPH | 100% | -1.91% | ||
NTLA - AUPH | 40% Loosely correlated | -3.65% | ||
ABCL - AUPH | 36% Loosely correlated | -2.34% | ||
ACLX - AUPH | 36% Loosely correlated | -3.81% | ||
AVXL - AUPH | 36% Loosely correlated | -9.30% | ||
ARCT - AUPH | 34% Loosely correlated | -8.10% | ||
More |
Ticker / NAME | Correlation To AUPH | 1D Price Change % |
---|---|---|
AUPH | 100% | -1.91% |
biopharmaceuticals theme (52 stocks) | 40% Loosely correlated | +2.00% |
cancer theme (87 stocks) | 37% Loosely correlated | +0.89% |
biotechnology theme (248 stocks) | 37% Loosely correlated | +5.56% |
drugs theme (265 stocks) | 36% Loosely correlated | +5.37% |
north america theme (189 stocks) | 29% Poorly correlated | -0.16% |